RSRafaela Kathrine Silva

Rafaela Kathrine Silva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rafaela Kathrine Silva has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Randomized clinical trial comparing removal followed by topical imiquimod versus removal followed by topical methylprednisolone in the treatment of keloids

    by Alexandre Spiandorello Ricciardi, Marcio Fernandes Chedid, Claudia Elizabeth Thompson, Rafaela Katrine da Silva, David Rubem Azulay, Mônica Manela-Azulay

    Purpose: Keloids are unaesthetic benign dermatosis characterized by a disorganized proliferation of collagen. Treatment of keloids constitutes a therapeutic challenge. The aim of this study was to evaluate the efficacy and effectiveness of topical imiquimod associated with surgical excision in the treatment of keloid. Methods: A randomized, double blind, matching-lesion (self-paired manner) clinical trial. Ten patients with two keloid lesions each in similar anatomical and contralateral areas (paired lesions) had their keloids excised, and the operative site treated with the application of 5% imiquimod cream or 0.1% methylprednisolone aceponate cream (gold standard) for eight weeks. Results: Eight patients (total = 16 lesions) completed the study. Four of the total eight keloids (50%) in the methylprednisolone group vs. 3/8 keloids (37.5%) in the imiquimod group recurred in the first post-treatment year (p 0.05). Conclusion: Surgical removal plus application of topical imiquimod was shown as safe, and its efficacy was not statistically inferior for the treatment of keloids as compared to methylprednisolone. Due to the lack of efficacy in most therapeutic modalities, surgical removal plus topical imiquimod could be recommended as an additional first line therapy and especially for recurrent keloids. Studies with larger samples are necessary to evaluatre therapies for keloids.


  • Open Access

    PARTIAL HEPATECTOMY USING LINEAR CUTTER STAPLER: ARE THERE ADVANTAGES?

    by Marcio Fernandes Chedid, Pietro Waltrick Brum, Tomaz de Jesus Maria Grezzana-Filho, Rafaela Kathrine da Silva, Pedro Funari Pereira, Aljamir Duarte Chedid, Cleber Rosito Pinto Kruel

    BACKGROUND: Morbidity of liver resections is related to intraoperative bleeding and postoperative biliary fistulas. The Endo-GIA stapler (EG) in liver resections is well established, but its cost is high, limiting its use. The linear cutting stapler (LCS) is a lower cost device. AIMS: To report open liver resections, using LCS for transection of the liver parenchyma and en bloc stapling of vessels and bile ducts. METHODS: Ten patients were included in the study. Four patients with severe abdominal pain had benign liver tumors (three adenomas and one focal nodular hyperplasia). Among the remaining six patients, four underwent liver resection for the treatment of colorectal liver metastases, three of which had undergone preoperative chemotherapy. The other two cases were one patient with metastasis from a testicular teratoma and the other with metastasis from a gastrointestinal neuroectodermal tumor. RESULTS: The average length of stay was five days (range 4–7 days). Of the seven patients who underwent resections of segments II/III, two presented postoperative complications: one developed a seroma and the other a collection of abdominal fluid who underwent percutaneous drainage, antibiotic therapy, and blood transfusion. Furthermore, the three patients who underwent major resections had postoperative complications: two developed anemia and received blood transfusions and one had biloma and underwent percutaneous drainage and antibiotic therapy. CONCLUSIONS: The use of the linear stapler in hepatectomies was efficient and at lower costs, making it suitable for use whenever EG is not available. The size of the LCS stapler shaft is more suitable for en bloc transection of the left lateral segment of the liver, which is thinner than the right one. Further studies are needed to evaluate the safety of LCS for large liver resections and resections of tumors located in the right hepatic lobe.


  • Open Access

    Acute-on-Chronic Liver Failure: Diagnóstico al Transplante Hepático

    by Jane Cronst, Marcelo de Abreu Pinto, Lucas Prediger, Rafaela Kathrine Silva, Soraia Arruda, Marcio Fernandes Chedid

    Resumen:Introducción: Pacientes en acute on chronic liver failure (ACLF)presentan características distintas de aquellas presentadas por pacientes hepatopatas no ACLF. El grado de ACLF impacta en el desenlace con o sin el transplante, habiendo divergencias en la literatura principalmente en lo que se refiere al pronóstico postransplante. Objetivos: Revisar los diferentes aspectos de los pacientes en ACLF, abarcando los conceptos del síndrome adoptados por diversas instituciones, el tratamiento de las complicaciones, y describir el conocimiento acerca de los desenlaces con o sin transplante de los portadores del síndrome reportados en la literatura. Métodos: Fueron incluidos 22 artículos encontrados en la búsqueda de bases de datos PubMed, Medline y Biblioteca Electrónica Científica Online (SciELO) con los descriptores “ACLF definitions” y “Liver transplantation ACLF”. Los conceptos y datos apuntados en los textos seleccionados fueron comparados y utilizados como base para redactar este artículo. Resultados: Existen algunas diferencias en la definición del síndrome, variando especialmente entre los países del Occidente y los del Oriente. Pacientes esperando transplante hepático en ACLFpresentan características distintas de aquellas presentadas por pacientes no ACLF. El grado de ACLF también impacta en el desenlace con o sin el transplante, habiendo divergencias en la literatura principalmente en lo que se refiere al pronóstico postransplante de los pacientes en ACLF 3, con tendencia cada vez mayor en la indicación del transplante incluso para estos pacientes. Conclusiones: Los desenlaces varían entre pacientes en ACLF de acuerdo con el grado de la enfermedad. El transplante hepático ha sido más frecuentemente indicado en ACLF 3, habiendo el tiempo de espera impactado los resultados. Son necesarios más estudios para definir cuáles subgrupos de pacientes se benefician más del transplante hepático.

  • Open Access

    Acute-on-Chronic Liver Failure: Diagnosis to Liver Transplantation

    by Jane Cronst, Marcelo de Abreu Pinto, Lucas Prediger, Rafaela Kathrine Silva, Soraia Arruda, Marcio Fernandes Chedid

    Introduction: Patients with acute-on-chronic liver failure(ACLF) have different characteristics from those presented by non-ACLF patients with liver diseases. The degree of ACLF impacts the outcome with or without transplantation, with divergences in the literature, especially regarding post-transplant prognosis. Objectives: To review the different aspects of patients with ACLF, including the concepts of the syndrome adopted by various institutions, the treatment of complications, and to describe the knowledge about the outcomes with or without transplantation of patients with the syndrome reported in the literature. Methods: Twenty-two articles were included in the PubMed, MEDLINE and the Scientific Electronic Library Online (SciELO) databases with the descriptors “ACLF definitions” and “Liver transplantation ACLF.” The concepts and data from the selected texts were compared and used as a basis for writing this article. Results: There are some differences in the definition of the syndrome, varying especially between Western and Eastern countries. ACLF patients awaiting liver transplantation have characteristics distinct from those presented by non-ACLF patients. The degree of ACLF also impacts the outcome with or without transplantation, with divergences in the literature especially regarding the post-transplant prognosis of ACLF-3 patients, with an increasing trend in the indication of transplantation even for these patients. Conclusions: Outcomes vary among ACLF patients according to the degree of the disease. Liver transplantation has been more frequently indicated in ACLF-3, with waiting time impacting outcomes. Further studies are needed to define which subgroups of patients benefit most from liver transplantation.

  • Open Access

    Acute-on-Chronic Liver Failure: Diagnóstico ao Transplante Hepático

    by Jane Cronst, Marcelo de Abreu Pinto, Lucas Prediger, Rafaela Kathrine Silva, Soraia Arruda, Marcio Fernandes Chedid

    Introdução: Pacientes em acute on chronic liver failure (ACLF) apresentam características distintas daquelas apresentadas por pacientes hepatopatas não ACLF. O grau de ACLF impacta no desfecho com ou sem o transplante, havendo divergências na literatura principalmente no que tange ao prognóstico pós-transplante. Objetivos: Revisar os diferentes aspectos dos pacientes em ACLF, abrangendo os conceitos da síndrome adotados por diversas instituições, o tratamento das complicações, e descrever o conhecimento acerca dos desfechos com ou sem transplante dos portadores da síndrome reportados na literatura. Métodos: Foram incluídos 22 artigos encontrados na busca de bases de dados PubMed, Medline e Biblioteca Eletrônica Científica Online (SciELO) com os descritores “ACLF definitions” e “Liver transplantation ACLF”. Os conceitos e dados apontados nos textos selecionados foram comparados e utilizados como base para redigir este artigo. Resultados: Existem algumas diferenças na definição da síndrome, variando especialmente entre os países do Ocidente e os do Oriente. Pacientes aguardando transplante hepático em ACLF apresentam características distintas daquelas apresentadas por pacientes não ACLF. O grau de ACLF também impacta no desfecho com ou sem o transplante, havendo divergências na literatura principalmente no que tange ao prognóstico pós-transplante dos pacientes em ACLF 3, com tendência cada vez maior na indicação do transplante mesmo para esses pacientes. Conclusões: Os desfechos variam entre pacientes em ACLF de acordo com o grau da doença. O transplante hepático tem sido mais frequentemente indicado em ACLF 3, tendo o tempo de espera impactado os resultados. São necessários mais estudos para definir quais subgrupos de pacientes se beneficiam mais do transplante hepático.